Twincretin drug Tirzepatide shows unmatched efficacy in weight loss and diabetes management

FHS
July 15, 2024
4:30 am

Tirzepatide, a novel twincretin drug, significantly improves weight loss and glycemic control in obese and type 2 diabetes patients, outperforming traditional treatments in clinical trials.

Exploring the protective effects of HSD17B13 in hepatic steatosis

Chronic liver disease (CLD) is a growing global health challenge, accounting for millions of deaths each year. Its major contributors include metabolic dysfunction-associated steatohepatitis (MASH),

November 9, 2024

Docs Accused of Treating Fatal COVID With Peroxide; Cardiologists’ Defamation Suit

A Tennessee family is suing physician Carrie Madej, DO, and two other doctors for allegedly treating their 80-year-old father’s COVID symptoms with hydrogen peroxide, leading

September 20, 2024

Combination drug therapy beats solo treatment for aggressive prostate cancer relapse

Combining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better than treatment with a single drug, a multi-institution, Phase 3

January 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.